Health2Tech

Mali Family Health founder Jonas Koblin explains why he chose a bootstrapped model for his pregnancy and baby tracker app. We cover monetization, realistic market sizing, and how to grow without VC money.

Ooca founder Dr. Kanpassorn Eix introduces Thailand’s healthcare system and her mental health telehealth platform. We discuss finding the right tech partner, scaling, and advice for founders in emerging markets.

YourCoach Health co-founder Eugene Borukhovich explains why health coaches are key to long-term behavior change. We talk about running an American company from Europe, coaching models, and lessons from his long digital health career.

Urologist Cristián Konstantinidis explains how robotic surgery is used today and why many surgeons never want to go back. We talk about Spain’s health system, interoperability, and philosophical questions around robots in the OR.

Xpeer founder Daniela Clape compares her Netflix-like medical education platform to traditional learning. We discuss idea validation, monetization, and the challenges of building EdTech in healthcare.

DiamPark founders Djamchid Dalili and Caroline Atlani describe building a digital biomarker startup for Parkinson’s disease. We explore patient-driven innovation, pharma partnerships, and why speed-to-market is critical for real patients.

Investor Didier Tranchier shares how Digital Pharma Lab supports startups and whether it still makes sense to invest in digital health in a global crisis. We talk about pharma’s role, France’s ecosystem, and funding strategy.

Consultant Wessel Kooyman explains what counts as Software as a Medical Device (SaMD) and what this means for developers. We go through needed skill sets, regulatory expectations, and how to manage a MedTech software company.

Professor Nick Guldemond talks about why many digital solutions fail to deliver real value to healthcare systems. We explore prevention, incentives, role models in global health, and what startups must understand about system design.

Lawyer Sebastian Vorberg breaks down the legal and regulatory steps to get DiGA approval. We discuss security, evidence requirements, FDA vs BfArM, and why the process has slowed after an initially fast start.